Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082251
Status:
COMPLETED
Last Update Posted:
2006-11-01
First Post:
2004-05-03
Brief Title:
Safety Efficacy of a Combination Niacin ERSimvastatin in Patients With Dyslipidemia A Dose-Ranging Study - SEACOAST
Sponsor:
Kos Pharmaceuticals
Organization:
Kos Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hypercholesterolemia |
Keywords:
| Name | View |
|---|---|
| Dyslipidemia | View |
| High Blood Cholesterol | View |
| Coronary Heart Disease | View |
| Hypertension | View |
| National Cholesterol Education Program | View |
| Adult Treatment Panel III | View |
| Niacin | View |
| Simvastatin | View |
| Diabetes | View |
| Peripheral Vascular Disease | View |
| Cerebrovascular disease | View |
| Stroke | View |
| High-Density Lipoprotein Cholesterol | View |
| Hydroxymethyl Glutaryl Coenzyme A | View |
| High-Sensitivity C-Reactive Protein | View |
| Low-Density Lipoprotein Cholesterol | View |
| Lipoprotein a | View |
| Lipoprotein A-I | View |
| Total Cholesterol | View |
| Triglycerides | View |